Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Translational precision medicine: an industry perspective

Fig. 2

Flow of clinical trials (interventional or non-interventional) integrating multi-omics approaches to identify disease endotypes, which enables biomarker-guided trials designs (adaptive or non-adaptive) and paves the way towards precision medicine approaches (tailoring treatments for personalised healthcare)

Back to article page